Helix Biopharma Corp HBP-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 07/30/21 EDT
0.83quote price arrow down-0.05 (-5.68%)
Volume
4,539
52 week range
0.25 - 1.16

...

Loading . . .
  • Open0.77
  • Day High0.83
  • Day Low0.77
  • Prev Close0.88
  • 52 Week High1.16
  • 52 Week High Date02/03/21
  • 52 Week Low0.25
  • 52 Week Low Date12/02/20

Key Stats

  • Market Cap94.24M
  • Shares Out141.13M
  • 10 Day Average Volume14,072.6
  • Dividend-
  • Dividend Yield-
  • Beta-0.16
  • YTD % Change66

KEY STATS

  • Open0.77
  • Day High0.83
  • Day Low0.77
  • Prev Close0.88
  • 52 Week High1.16
  • 52 Week High Date02/03/21
  • 52 Week Low0.25
  • 52 Week Low Date12/02/20
  • Market Cap94.24M
  • Shares Out141.13M
  • 10 Day Average Volume14,072.6
  • Dividend-
  • Dividend Yield-
  • Beta-0.16
  • YTD % Change66

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-12.91
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Helix Biopharma Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Helix BioPharma Corp. is an immuno-oncology company, which specializes in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its technologies. The Company's product development initiatives are focused primarily on technologies that modulate the tumor microenvironment. The Company's technology platform, DOS47 yielded approximately two drug product candidates, L-DOS47 and vDOS47. L-DOS47 is an antibody protein...
Slawomir Majewski M.D.
Chairman
Heman Chao Ph.D.
Chief Executive Officer
Photios Michalargias CPA
Chief Financial Officer
Address
9120 Leslie St Suite 205
Richmond Hill, ON
L4B 3J9
Canada

Top Peers

SYMBOLLASTCHG%CHG
IMV
IMV Inc
1.79+0.05+2.87%
CRDL
Cardiol Therapeutics Inc
2.83+0.18+6.79%
MDNA
Medicenna Therapeutics Corp
2.51+0.01+0.40%
DMAC
DiaMedica Therapeutics Inc
3.45-0.17-4.70%
EDSA
Edesa Biotech Inc
5.00+0.07+1.42%